Doerfler A, Goericke S, Wanke I, Holla M, Forsting M
Department of Neuroradiology, University of Essen Medical School, Germany.
Neuroradiology. 2001 Dec;43(12):1112-7. doi: 10.1007/s002340100653.
We conducted an in vitro performance study to test the flow-directed Spinnaker microcatheter for potential endovascular embolizations with Ethibloc as embolic agent. We performed in vitro testing using 50 Spinnaker 1.8F hydrophilic infusion microcatheters of three different types. As embolic agent, different mixtures of Ethibloc and Lipiodol (E/L 1:1, 1:2, 1:3) were used. In an in vitro setting, each catheter was injected to a maximum of ten times (E/L 1:1, n = 20 catheters; E/L 1:2, n = 20; E/L 1:3, n = 10). In addition, we evaluated the thinner Spinnaker 1.5F microcatheter (165/20, n = 10). Five Spinnaker 1.5F catheters were each injected with a mixture of Ethibloc and Lipiodol (E/L 1:2 and 1:3). When a mixture of E/L 1:1 was used, 9 of 20 (45%) Spinnaker 1.8F microcatheters ruptured distally near the tip of the microcatheter, each during injection nos. 5-9. One Spinnaker 1.8F was distally occluded after the fifth injection. With a mixture of E/L 1:2, 4 of 20 (20%) Spinnaker 1.8F microcatheters ruptured distally, during injection no. 6 (n = 2), 7 (n = 1), and 8 (n = 1). With a mixture of E/L 1:3, all ten Spinnaker 1.8F microcatheters could be injected without any problems. All ten microcatheters of the thinner Spinnaker 1.5F ruptured (10-18 cm proximally to the catheter tip). This in vitro study using the flow-directed Spinnaker microcatheter revealed that microcatheters can rupture. The Spinnaker 1.8F can rupture when a mixture of Ethibloc and Lipiodol 1:1 or 1:2 and more than four injections are used. The Spinnaker 1.8F does not rupture when a mixture of E/L 1:3 is used, or with a mixture of E/L 1:1 or 1:2 and injecting to a maximum of four times. The Spinnaker 1.5F microcatheter is not suitable for embolizations using Ethibloc. For embolizations with Ethibloc we therefore recommend the use of a guidewire-directed microcatheter.
我们进行了一项体外性能研究,以测试用于潜在血管内栓塞的血流导向型Spinnaker微导管,栓塞剂为Ethibloc。我们使用了三种不同类型的50根Spinnaker 1.8F亲水灌注微导管进行体外测试。作为栓塞剂,使用了Ethibloc和碘油的不同混合物(E/L 1:1、1:2、1:3)。在体外环境中,每根导管最多注射十次(E/L 1:1,n = 20根导管;E/L 1:2,n = 20;E/L 1:3,n = 10)。此外,我们评估了更细的Spinnaker 1.5F微导管(165/20,n = 10)。五根Spinnaker 1.5F导管分别注射了Ethibloc和碘油的混合物(E/L 1:2和1:3)。当使用E/L 1:1混合物时,20根Spinnaker 1.8F微导管中有9根(45%)在微导管尖端附近的远端破裂,均在第5 - 9次注射期间。一根Spinnaker 1.8F在第五次注射后远端堵塞。使用E/L 1:2混合物时,20根Spinnaker 1.8F微导管中有4根(20%)在远端破裂,分别在第6次(n = 2)、第7次(n = 1)和第8次(n = 1)注射时。使用E/L 1:3混合物时,所有十根Spinnaker 1.8F微导管均可顺利注射。更细的Spinnaker 1.5F的所有十根微导管均破裂(在导管尖端近端10 - 18厘米处)。这项使用血流导向型Spinnaker微导管的体外研究表明微导管可能会破裂。当使用Ethibloc和碘油1:1或1:2的混合物且注射超过四次时,Spinnaker 1.8F可能会破裂。当使用E/L 1:3混合物时,或使用E/L 1:1或1:2的混合物且最多注射四次时,Spinnaker 1.8F不会破裂。Spinnaker 1.5F微导管不适合使用Ethibloc进行栓塞。因此,对于使用Ethibloc进行栓塞,我们建议使用导丝导向的微导管。